期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (9)
BackgroundA major challenge in stage II colorectal carcinoma is to identify patients with increased risk of recurrence. Biomarkers that distinguish pa......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (9)
Background: Establishing the existence of health inequalities remains a high research and policy agenda item in the United Kingdom. We describe ethnic......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (10)
BackgroundOutcomes for patients with metastatic renal cell carcinoma (mRCC) and tumour thrombus remain poor. Recent data suggest limited role for cyto......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (10)
Background One-third of cancers activate endogenous synthesis of serine/glycine, and can become addicted to this pathway to sustain proliferation and ......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (11)
BackgroundHPV-related cervical cancer (CC) is the fourth most frequent cancer in women worldwide. Cell-free tumour DNA is a potent biomarker to detect......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (11)
Background: Enhancing the response rate of immunotherapy will aid in the success of cancer treatment. Here, we aimed to explore the combined effect of......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (11)
BackgroundPancreatic ductal adenocarcinoma (PDAC) is highly malignant with a very poor prognosis due to its silent development and metastatic profile ......
期刊: BRITISH JOURNAL OF CANCER, 2023; 129 (10)
Background: Oral epithelial dysplasia (OED) is the precursor to oral squamous cell carcinoma which is amongst the top ten cancers worldwide. Prognosti......
期刊: BRITISH JOURNAL OF CANCER, 2023; 129 (10)
BACKGROUND: To investigate the predictive ability of high-throughput MRI with deep survival networks for biochemical recurrence (BCR) of prostate canc......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (6)
BackgroundGRP78 has been implicated in hepatocarcinogenesis. However, the clinical relevance, biological functions and related regulatory mechanisms o......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (9)
In the UK, the National Institute for Health and Care Excellence (NICE) recommends that women at moderate or high risk of breast cancer be offered ris......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (9)
Breast cancer (BC) is the most commonly diagnosed form of cancer and a leading cause of cancer-related deaths among women worldwide. Yes-associated pr......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (12)
BackgroundOnly a subset of gastric cancer (GC) patients with stage II-III benefits from chemotherapy after surgery. Tumour infiltrating lymphocytes pe......
期刊: BRITISH JOURNAL OF CANCER, 2023; 128 (12)
Background: Driver alterations may represent novel candidates for driver gene-guided therapy; however, intrahepatic cholangiocarcinoma (ICC) with mult......
期刊: BRITISH JOURNAL OF CANCER, 2023; 129 (2)
BackgroundStudies to date have yielded inconclusive results as to whether maternal medical history during pregnancy, and a child's early-life medical ......